Literature DB >> 8682782

Active efflux of fluoroquinolones in Mycobacterium smegmatis mediated by LfrA, a multidrug efflux pump.

J Liu1, H E Takiff, H Nikaido.   

Abstract

The lfrA gene cloned from chromosomal DNA of quinolone-resistant Mycobacterium smegmatis mc2-552 conferred low-level resistance to fluoroquinolones when present on multicopy plasmids. Sequence analysis suggested that lfrA encodes a membrane efflux pump of the major facilitator family (H. E. Takiff, M. Cimino, M. C. Musso, T. Weisbrod, R. Martinez, M. B. Delgado, L Salazar, B. R. Bloom, and W. R. Jacbos, Jr., Proc. Natl. Acad. Sci. USA 93:362-366, 1996). In this work, we studied the role of LfrA in the accumulation of fluoroquinolones by M. smegmatis. The steady-state accumulation level of a hydrophilic quinolone, norfloxacin, by M. smegmatis harboring a plasmid carrying the lfrA gene was about 50% of that by the parent strain but was increased to the same level as that of the parent strain by addition of a proton conductor, carbonyl cyanide m-chorophenylhydrazone. Norfloxacin efflux mediated by LfrA was competed for strongly by ciprofloxacin but not by nalidixic acid. Furthermore, we showed that portions of norfloxacin accumulated by starved cells were pumped out upon reenergization of the cells, and the rates of this efflux showed evidence of saturation at higher intracellular concentrations of the drug. These results suggest that the LfrA polypeptide catalyzes the active efflux of several quinolones.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682782      PMCID: PMC232638          DOI: 10.1128/jb.178.13.3791-3795.1996

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  35 in total

Review 1.  Mycobacterial cell wall: structure and role in natural resistance to antibiotics.

Authors:  V Jarlier; H Nikaido
Journal:  FEMS Microbiol Lett       Date:  1994-10-15       Impact factor: 2.742

2.  Selection of a gyrA mutant of Mycobacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin.

Authors:  E Cambau; W Sougakoff; M Besson; C Truffot-Pernot; J Grosset; V Jarlier
Journal:  J Infect Dis       Date:  1994-08       Impact factor: 5.226

3.  Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome.

Authors:  E Y Ng; M Trucksis; D C Hooper
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 4.  The envelope of mycobacteria.

Authors:  P J Brennan; H Nikaido
Journal:  Annu Rev Biochem       Date:  1995       Impact factor: 23.643

5.  Emergence of fluoroquinolone-resistant tuberculosis in New York City.

Authors:  E A Sullivan; B N Kreiswirth; L Palumbo; V Kapur; J M Musser; A Ebrahimzadeh; T R Frieden
Journal:  Lancet       Date:  1995-05-06       Impact factor: 79.321

6.  Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus.

Authors:  H Ito; H Yoshida; M Bogaki-Shonai; T Niga; H Hattori; S Nakamura
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

7.  Permeability of the cell wall of Mycobacterium smegmatis.

Authors:  J Trias; R Benz
Journal:  Mol Microbiol       Date:  1994-10       Impact factor: 3.501

8.  Role of efflux pump(s) in intrinsic resistance of Pseudomonas aeruginosa: resistance to tetracycline, chloramphenicol, and norfloxacin.

Authors:  X Z Li; D M Livermore; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1994-08       Impact factor: 5.191

9.  Outer membrane proteins responsible for multiple drug resistance in Pseudomonas aeruginosa.

Authors:  N Masuda; E Sakagawa; S Ohya
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

10.  Role of outer membrane barrier in efflux-mediated tetracycline resistance of Escherichia coli.

Authors:  D G Thanassi; G S Suh; H Nikaido
Journal:  J Bacteriol       Date:  1995-02       Impact factor: 3.490

View more
  43 in total

Review 1.  Molecular properties of bacterial multidrug transporters.

Authors:  M Putman; H W van Veen; W N Konings
Journal:  Microbiol Mol Biol Rev       Date:  2000-12       Impact factor: 11.056

Review 2.  Efflux-mediated resistance to fluoroquinolones in gram-positive bacteria and the mycobacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

Review 3.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Pyrazinoic acid efflux rate in Mycobacterium tuberculosis is a better proxy of pyrazinamide resistance.

Authors:  Mirko Zimic; Patricia Fuentes; Robert H Gilman; Andrés H Gutiérrez; Daniela Kirwan; Patricia Sheen
Journal:  Tuberculosis (Edinb)       Date:  2011-10-17       Impact factor: 3.131

5.  AsnB is involved in natural resistance of Mycobacterium smegmatis to multiple drugs.

Authors:  Huiping Ren; Jun Liu
Journal:  Antimicrob Agents Chemother       Date:  2006-01       Impact factor: 5.191

Review 6.  A balancing act: efflux/influx in mycobacterial drug resistance.

Authors:  G E Louw; R M Warren; N C Gey van Pittius; C R E McEvoy; P D Van Helden; T C Victor
Journal:  Antimicrob Agents Chemother       Date:  2009-05-18       Impact factor: 5.191

7.  Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator.

Authors:  Marco Bellinzoni; Silvia Buroni; Francis Schaeffer; Giovanna Riccardi; Edda De Rossi; Pedro M Alzari
Journal:  J Bacteriol       Date:  2009-10-09       Impact factor: 3.490

Review 8.  Proton-dependent multidrug efflux systems.

Authors:  I T Paulsen; M H Brown; R A Skurray
Journal:  Microbiol Rev       Date:  1996-12

9.  Antimicrobial efflux pumps and Mycobacterium tuberculosis drug tolerance: evolutionary considerations.

Authors:  John D Szumowski; Kristin N Adams; Paul H Edelstein; Lalita Ramakrishnan
Journal:  Curr Top Microbiol Immunol       Date:  2013       Impact factor: 4.291

10.  Impact of methoxymycolic acid production by Mycobacterium bovis BCG vaccines.

Authors:  Adam Belley; David Alexander; Tania Di Pietrantonio; Manon Girard; Joses Jones; Erwin Schurr; Jun Liu; David R Sherman; Marcel A Behr
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.